Nexalin Technology, Inc.

NXL

Nexalin Technology, Inc.

NXL

Insider Sentiment (TTM):

Last Purchase:2025-03-12Last Sale:-Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:1,032,553Shares Outstanding:19,820,910Institutional Ownership Pct.:5.21%

Earnings Market Reaction:

Filing Date:2026-08-12Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	1	1	1	1	0	1	1	0	1	1	1	0
Short Term Investments	-	2	3	4	5	1	3	5	-	2	2	4
Accounts Receivable Net Current	0	0	0	0	0	0	0	0	0	0	0	0
Inventory Net	0	0	0	0	0	0	0	0	0	0	0	0
Prepaid Expense And Other Assets Current	1	0	0	0	0	0	0	0	0	0	0	0
Assets Current	2	3	4	5	6	3	4	5	1	3	3	4
Operating Lease Right Of Use Asset	-	-	-	-	-	-	-	-	-	-	0	0
Property Plant And Equipment Net	-	-	-	-	-	-	-	-	-	-	-	0
Finite Lived Intangible Assets Net	0	0	0	0	0	0	0	0	0	0	0	-
Equity Method Investments	-	-	-	-	-	0	0	0	0	0	0	0
Other Assets	-	-	-	0	0	-	0	-	-	-	-	-
Assets	3	4	5	5	7	3	4	5	2	3	4	4
Liabilities And Stockhold…
Other Assets Noncurrent	-	-	-	-	-	-	-	-	0	-	-	-
Liabilities Current
Accounts Payable Current	0	0	0	0	0	0	0	0	0	0	0	0
Accrued Liabilities Current	1	1	1	0	0	0	0	0	0	0	0	1
Operating Lease Liability Current	-	-	-	-	-	-	-	-	-	-	0	0
Notes Payable Current	-	-	-	-	-	-	-	-	-	-	-	1
Liabilities Current	1	1	1	0	1	1	1	0	0	1	0	1
Liabilities	1	1	1	0	1	1	1	0	0	1	0	1
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated Other Comprehensive Income Loss Net Of…	-	0	0	-0	0	0	-0	-0	-	-0	-0	0
Liabilities Noncurrent
Additional Paid In Capital	99	98	97	95	94	89	88	87	81	80	80	79
Retained Earnings Accumulated Deficit	-97	-95	-93	-90	-88	-87	-85	-82	-79	-78	-77	-76
Stockholders Equity	2	3	4	5	6	2	4	5	1	2	3	3
Commitments And Contingen…
Liabilities And Stockholders Equity	3	4	5	5	7	3	4	5	2	3	4	4
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	100	100	100	100	100	100	100	100	100	100	100	100
Common Stock Shares Issued	22	21	19	18	17	13	13	13	8	7	7	7
Shares Outstanding	22	21	19	18	17	13	13	13	8	7	7	7
Accumulated Depreciation Depletion And Amortizatio…	-	-	-	-	-	-	-	-	-	-	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	73.30%	0.85%	36.65%	-	-	-	-	-	-	-	-	-
2025	8.40%	-19.33%	-16.89%	-3.43%	-5.45%	45.45%	-10.19%	-46.02%	-47.22%	16.92%	-13.38%	8.84%
2024	-45.31%	32.03%	-3.12%	1.54%	-22.16%	152.48%	10.00%	-22.37%	-28.42%	-21.40%	-16.74%	-44.65%
2023	-	-	-	-	-	-	11.76%	14.71%	12.65%	83.33%	67.95%	15.26%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.25	4.07	4.85	13.47	10.44	4.56	7.25	16.39	5.57	5.05	8.07	3.56
Quick Ratio	0.71	3.40	4.29	12.20	9.74	3.59	6.39	15.39	4.06	4.23	6.95	3.30
Working Capital	377.35K	2.48M	3.41M	4.46M	5.67M	2.05M	3.41M	4.61M	970.04K	2.06M	3.00M	3.07M
Leverage & Debt
Debt to Equity	0.98	0.28	0.24	0.07	0.10	0.25	0.15	0.06	0.16	0.22	0.13	0.37
Interest Coverage TTM	-3,496.56	-1,185.27	-1,018.31	-893.89	-1,046.42	-2,177.39	-2,428.64	-316.95	-257.98	-197.70	-146.68	-62.69
Debt Ratio	0.49	0.22	0.19	0.07	0.09	0.20	0.13	0.06	0.14	0.18	0.12	0.27
Efficiency & Turnover
Asset Turnover TTM	0.05	0.08	0.07	0.03	0.04	0.05	0.04	0.03	0.04	0.04	0.02	0.14
Days Sales Outstanding TTM	94.77	38.07	57.24	26.86	74.71	25.27	24.24	33.39	31.65	8.29	23.47	5.23
Receivables Turnover TTM	3.85	9.59	6.38	13.59	4.89	14.45	15.06	10.93	11.53	44.03	15.55	69.76
Per Share Metrics
Diluted EPS TTM	-0.43	-0.42	-0.50	-0.49	-0.56	-0.64	-0.83	-0.51	-0.72	-0.66	-0.63	-0.73
Free Cash Flow Per Share TTM	-0.28	-0.27	-0.31	-0.20	-0.19	-0.35	-0.44	-0.36	-0.51	-0.45	-0.53	-0.52
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	86.16%	81.99%	79.65%	69.52%	67.63%	68.72%	78.31%	78.82%	82.95%	82.54%	76.80%	77.33%
Operating Profit Margin TTM	-4,202.54%	-3,084.22%	-2,781.69%	-5,641.40%	-5,157.51%	-6,631.95%	-4,596.14%	-4,012.74%	-4,269.30%	-3,771.01%	-5,143.48%	-647.81%
Net Profit Margin TTM	-4,139.38%	-3,022.94%	-2,725.76%	-5,530.40%	-5,063.04%	-6,526.81%	-4,508.73%	-3,427.12%	-3,598.52%	-3,110.59%	-4,197.56%	-626.89%
Growth Metrics
Net Revenue Growth (1Y)	24.22%	110.26%	78.78%	-3.18%	16.42%	-17.50%	52.35%	-81.29%	-89.18%	-	-	-
Net Income Growth (1Y)	1.56%	-2.61%	8.08%	56.25%	63.80%	73.11%	63.64%	2.29%	65.31%	-	-	-
EPS Growth (1Y)	-24.50%	-34.62%	-39.24%	-4.75%	-21.87%	-3.26%	30.64%	-30.08%	60.66%	-	-	-
Valuation Metrics
P/E TTM	-0.78	-0.83	-1.11	-1.88	-1.75	-3.03	-3.34	-1.31	-2.34	-2.11	-0.64	-0.60
P/B TTM	4.59	2.39	2.44	3.42	2.60	11.16	6.92	1.46	9.38	4.47	0.93	1.01
P/S TTM	32.13	25.03	30.32	103.98	88.84	197.99	150.75	44.77	84.38	65.54	26.90	3.77
Market Cap	6.98M	6.90M	9.15M	16.32M	15.53M	25.95M	25.44M	7.26M	12.67M	10.41M	2.98M	3.26M
Enterprise Value	5.97M	5.69M	8.49M	15.73M	15.10M	25.33M	24.86M	7.18M	11.82M	9.86M	2.40M	3.40M
Calculated Values
Free Cash Flow TTM	-5.92M	-5.31M	-5.03M	-3.57M	-2.91M	-4.70M	-4.06M	-3.92M	-3.83M	-3.38M	-3.93M	-3.83M
Net Debt	-1.00M	-1.21M	-654.78K	-590.08K	-431.32K	-622.03K	-574.49K	-81.42K	-848.80K	-546.26K	-580.23K	138.60K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-03-12Purchase

Owner: Shelton, Carolyn Hamby

Title: Sr. VP - Quality, Regulatory

Shares: 6,000

Price/Share: $2.20

Value: $13,200.00

Shares Owned: 30,000

Relationship: Officer

Ownership: Indirect

2025-02-04Purchase

Owner: Owens, David

Title: Chief Medical Officer

Shares: 1,000

Price/Share: $3.10

Value: $3,100.00

Shares Owned: 155,793

Relationship: Director,Officer

Ownership: Direct

2025-01-28Purchase

Owner: Owens, David

Title: Chief Medical Officer

Shares: 1,500

Price/Share: $2.70

Value: $4,050.00

Shares Owned: 153,793

Relationship: Director,Officer

Ownership: Direct

2025-01-23Purchase

Owner: Owens, David

Title: Chief Medical Officer

Shares: 1,000

Price/Share: $2.70

Value: $2,700.00

Shares Owned: 152,293

Relationship: Director,Officer

Ownership: Direct

2024-12-20Purchase

Owner: Owens, David

Title: Chief Medical Officer

Shares: 1,000

Price/Share: $2.75

Value: $2,750.00

Shares Owned: 149,293

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-03-12	Shelton, Carolyn Hamby	Officer	Sr. VP - Quality, Regulatory	Indirect	Purchase	6,000	2.20	$13,200.00	30,000	4
2025-02-04	Owens, David	Director,Officer	Chief Medical Officer	Direct	Purchase	1,000	3.10	$3,100.00	155,793	4
2025-01-28	Owens, David	Director,Officer	Chief Medical Officer	Direct	Purchase	1,500	2.70	$4,050.00	153,793	4
2025-01-23	Owens, David	Director,Officer	Chief Medical Officer	Direct	Purchase	1,000	2.70	$2,700.00	152,293	4
2024-12-20	Owens, David	Director,Officer	Chief Medical Officer	Direct	Purchase	1,000	2.75	$2,750.00	149,293	5
2024-10-28	Owens, David	Director,Officer	Chief Medical Officer	Direct	Purchase	500	2.19	$1,095.00	148,293	4
2024-10-14	Shelton, Carolyn Hamby	Officer	Senior VP	Direct	Purchase	24,000	0.85	$20,400.00	24,000	5
2024-08-13	Owens, David	Director,Officer	Chief Medical Officer	Direct	Purchase	1,000	0.95	$950.00	147,793	4
2024-06-28	Owens, David	Director,Officer	Chief Medical Officer	Direct	Purchase	1,000	1.75	$1,750.00	146,793	4
2024-06-18	Owens, David	Director,Officer	Chief Medical Officer	Direct	Purchase	1,619	0.71	$1,149.49	145,793	4
2024-06-10	Owens, David	Director,Officer	Chief Medical Officer	Direct	Purchase	3,000	0.64	$1,920.00	144,174	4
2022-09-28	Osser, Leonard, Elson Mar…	Officer,TenPercentOwner	Ms. Elson serves as CFO	Indirect	Purchase	9,500	1.12	$10,640.00	835,244	4
2022-09-16	Morad, Rick	Director	-	Direct	Purchase	2,500	4.15	$10,375.00	108,341	4/A
2022-09-16	White, Mark	Director,Officer	President/CEO	Direct	Purchase	2,500	4.15	$10,375.00	289,627	4
2022-09-16	Kazden, Alan	Director	-	Indirect	Purchase	2,500	4.15	$10,375.00	89,131	4
2022-09-16	Owens, David	Director,Officer	Chief Medical Officer	Direct	Purchase	2,500	4.15	$10,375.00	141,174	4
2022-09-16	Osser, Leonard, Elson Mar…	Officer,TenPercentOwner	Ms. Elson serves as CFO	Direct	Purchase	36,000	4.15	$149,400.00	825,744	4
2022-09-16	Morad, Rick	Director	-	Direct	Purchase	2,500	4.15	$10,375.00	107,989	4
2022-09-16	Kazden, Alan	Director	-	Indirect	Purchase	2,500	4.15	$10,375.00	83,131	4/A
2022-09-15	White, Mark	Director,Officer	President/CEO	Direct	Purchase	25,000	4.15	$103,750.00	309,127	4/A
2022-09-15	White, Mark	Director,Officer	President/CEO	Direct	Purchase	25,000	4.15	$103,750.00	289,627	4/A
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

5.21%

Inst. Shares: 1,032,553

Shares Outstanding: 19,820,910

2025-12-31

7.22%

Inst. Shares: 1,183,918

Shares Outstanding: 16,392,465

2025-09-30

3.91%

Inst. Shares: 695,587

Shares Outstanding: 17,793,828

2025-06-30

8.36%

Inst. Shares: 1,314,236

Shares Outstanding: 15,718,149

2025-03-31

2.98%

Inst. Shares: 397,116

Shares Outstanding: 13,307,319

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	1,032,553	19,820,910	5.21%
2025-12-31	1,183,918	16,392,465	7.22%
2025-09-30	695,587	17,793,828	3.91%
2025-06-30	1,314,236	15,718,149	8.36%
2025-03-31	397,116	13,307,319	2.98%
2024-12-31	371,326	9,215,772	4.03%
2024-09-30	404,826	10,847,476	3.73%
2024-06-30	276,263	7,497,551	3.68%
2024-03-31	63,466	7,436,562	0.85%
2023-12-31	47,980	7,357,029	0.65%
2023-09-30	81,246	7,415,366	1.10%
2023-06-30	12,338	7,286,562	0.17%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Nexalin Technology, Inc. (NXL) — SEC Financial Statements & Analysis

Nexalin Technology, Inc. (NXL) is a electromedical & electrotherapeutic apparatus company, incorporated in DE. Nexalin Technology, Inc. trades on Nasdaq as: NXL. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Nexalin Technology, Inc. reported a 24.22% year-over-year revenue growth, a Gross Profit Margin of 86.16% (TTM), a Debt-to-Equity ratio of 0.98x, a Price-to-Sales (P/S) ratio of 32.13x (TTM), a Price-to-Book (P/B) ratio of 4.59x (TTM), at a market cap of $6.98M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 24.22%
Gross Profit Margin TTM: 86.16%
Debt To Equity: 0.98x
P/S TTM: 32.13x
P/B TTM: 4.59x
Market Cap: $6.98M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Nexalin Technology, Inc. in?

Nexalin Technology, Inc. (NXL) operates in the Electromedical & Electrotherapeutic Apparatus industry.

What is NXL's market cap?

Nexalin Technology, Inc. (NXL) has a market capitalization of $6.98M as of 2026-06-30.

What exchange does NXL trade on?

Nexalin Technology, Inc. (NXL) trades on the Nasdaq.

Where is Nexalin Technology, Inc. incorporated?

Nexalin Technology, Inc. is incorporated in DE.